The best Bull and Bear pitches based on recency and number of recommendations.
Argos Therapeutics, Inc. appears to be doing well in the clinical trials of their "Arcelis" immunotherapy product. Additional funding has done well.While still a risk, I expect this stock to outperform.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about ARGS.
Find the members with the highest scoring picks in ARGS.
CarsonCityFool (20.31) Score: +275.48
The Score Leader is the player with the highest score across all their picks in ARGS.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
CarsonCityFool | 20.31 |
|
1Y | $63.20 | -99.57% | +175.91% | +275.48 | 0 Comment | ||
jasonrivera | 28.04 | 1/13/2016 | 5Y | $38.20 | -99.29% | +175.76% | +275.06 | 0 Comment | ||
bonznstonz | 66.26 | 2/27/2017 | NS | $24.00 | -98.87% | +121.04% | -219.91 | 0 Comment | ||
LifeDaddy | < 20 | 6/9/2016 | 5Y | $146.00 | -99.81% | +146.79% | -246.60 | 0 Comment | ||
keithfredrickson | < 20 | 11/20/2015 | 5Y | $85.80 | -99.69% | +149.66% | -249.34 | 0 Comment | ||
biotracking | < 20 | 1/28/2015 | 5Y | $158.00 | -99.83% | +156.72% | -256.55 | 0 Comment | ||
stainsolution | < 20 | 12/21/2015 | 5Y | $38.40 | -99.30% | +159.70% | -259.00 | 0 Comment | ||
lrinnier39 | < 20 | 9/10/2014 | 5Y | $199.40 | -99.86% | +162.28% | -262.15 | 0 Comment | ||
ran6162 | < 20 | 3/3/2016 | 1Y | $107.81 | -99.75% | +162.99% | -262.74 | 0 Comment | ||
manirg | < 20 | 9/8/2015 | 5Y | $125.52 | -99.78% | +167.19% | -266.97 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.